NeoGenomics, Inc. Equity-NMS: NEO

$5.67 0.51 (August 5, 2025)

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$5.16
Open :$5.21
Today's high :$5.7
Today's low :$5.09
52W low :$4.72
52W high :$19.115
EPS(TTM): :-0.82
Shares O/S :129.18 M
Market cap :732.44 M

Compare with Other Stocks

Frequently Asked Questions

What is the share price of NeoGenomics, Inc. today?

NeoGenomics, Inc. (NEO) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of NeoGenomics, Inc.?

Yes, Indian Investors can invest in the NeoGenomics, Inc. (NEO) Share by opening an international trading account with Angel One.

How can I purchase NeoGenomics, Inc. shares in India?

Purchasing NeoGenomics, Inc. (NEO) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying NeoGenomics, Inc. (NEO) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of NeoGenomics, Inc.?

Yes, you can purchase fractional shares of NeoGenomics, Inc. (NEO) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of NeoGenomics, Inc.?

The market capitalization of NeoGenomics, Inc. on January 1, 1970, is $0.

What documents are required to invest in NeoGenomics, Inc. stocks?

In order to invest in NeoGenomics, Inc. (NEO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About NeoGenomics, Inc.

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.